New CAR T cells offer controlled treatment for solid tumors

Ludwig Cancer Research scientists have devised new types of chimeric antigen-receptor (CAR) T cells-;a type of cancer immunotherapy-;that can be switched on to varying degrees of intensity and then switched off on demand with existing drugs.

Senate Hearing Tackles Private Equity’s Impact on Healthcare Amid Steward Saga

In the wake of a deal for financially strapped Steward Health Care to sell its nationwide physician practice to UnitedHealth Group subsidiary Optum, a Senate

April 4, 2024

Tectonic to raise $185M; Acelyrin drops rights to Affibody drug

Plus, news about Immunome, 89bio and Valneva: Tectonic’s $185M private placement: After a hectic week of stock swings, Tectonic Therapeutic Sign up to read this

February 4, 2025

Pfizer CEO Albert Bourla inflicts injury on his company — and all of pharma

It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer. Pfizer’s decision to hire

February 24, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.